Results 171 to 180 of about 65,038 (202)
Some of the next articles are maybe not open access.

CD5 Positive and Negative B‐CLL

Annals of the New York Academy of Sciences, 1992
G B, Faguet   +3 more
openaire   +2 more sources

CD4, CD8 and NK subsets in B-CLL.

Nouvelle revue francaise d'hematologie, 1989
Although B-CLL is a hematological disorder characterized by clonal proliferation of B-cells, in most cases an increase in absolute numbers of T cells is observed. This increase is probably polyclonal in nature, since most data indicate that T lymphocytes are not progeny of the malignant clone in B-CLL.
F, Vuillier   +3 more
openaire   +1 more source

Activation of STAT 6 in B-CLL

Immunology Letters, 1997
C. Kneitz   +4 more
openaire   +2 more sources

Biology of the neoplastic lymphocyte in B-CLL.

Bailliere's clinical haematology, 1994
Immunological markers have identified the proliferating lymphocyte in CLL as a mature B lymphocyte which, unlike lymphocytes in other B cell malignancies, expresses low amounts of surface membrane immunoglobulin (smIg), forms rosettes with mouse erythrocytes and expresses the CD5 marker.
openaire   +1 more source

Molecular and cellular mechanisms of CLL: novel therapeutic approaches

Nature Reviews Clinical Oncology, 2009
Alexander Egle   +2 more
exaly  

B-CLL

2011
openaire   +1 more source

Molecular basis of CLL

Seminars in Cancer Biology, 2010
Yuri Pekarsky, Carlo Maria Croce
exaly  

B-CLL influence on T cell functions

European Journal of Cancer and Clinical Oncology, 1991
K.Y. Shevela   +3 more
openaire   +1 more source

IGLV3-21 * 01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling

Proceedings of the National Academy of Sciences of the United States of America, 2020
Palash C Maity   +2 more
exaly  

Home - About - Disclaimer - Privacy